Ani pharmaceuticals announces the fda approval and launch of estradiol tablets usp

Baudette, minn., sept. 12, 2023 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that it received u.s. food and drug administration (fda) approval for the abbreviated new drug application (anda) for estradiol tablets usp.

ANIP Ratings Summary

ANIP Quant Ranking